ClinicalTrials.Veeva

Menu

The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD

G

General Hospital of Chinese Armed Police Forces

Status

Unknown

Conditions

Duchenne Muscular Dystrophy (DMD)

Treatments

Procedure: Remote Ischemic Preconditioning Training Apparatus

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Background: Duchenne muscular dystrophy (DMD) is an X chromosome recessive hereditary disease and mainly characterized by progressive muscle weakness and atrophy. Glucocorticoid is the only proven effective medicine,while side effects limit its use. Recent studies have shown that the vascular density in the DMD patients' muscle is decreased,so muscle are in ischemic and anoxic. Remote ischemic preconditioning(RIPC) can improve the capable of resistanting ischemia and hypoxia and maybe a potential therapy for DMD patients.

Methods: 100 patients (aged 2 to 6 years)will be divided into two groups(treatment and control groups) randomly. Treatment group will receive an RIPC stimulus (inflation of a blood pressure cuff on the bilateral thighs to 150 mm Hg for four 5-minute intervals) while control group will receive a similar stimulus (inflation of a blood pressure cuff on the bilateral thighs to 40 mm Hg for four 5-minute intervals). Serum kinase level ,Blood levels of myoglobin, Evaluation of motor function(Four steps test;6-minute walking test) and MRI of lower limbs)at 0 days, 3 days, 3months ,6months.

Purpose:

  1. To evaluate the safety and tolerability of remote ischemic preconditioning for DMD patients
  2. To identify the effectiveness of remote ischemic preconditioning for DMD patients.

Enrollment

100 estimated patients

Sex

Male

Ages

2 to 6 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:Genetic analysis of DMD; from 2 to 6 years old ;without other diseases .

Exclusion Criteria: other congenital diseases;upper respiratory infection, gastroenteritis, vaccination, trauma.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

treatment group
Experimental group
Description:
inflation of a blood pressure cuff on the bilateral thighs to 150 mm Hg for four 5-minute intervals
Treatment:
Procedure: Remote Ischemic Preconditioning Training Apparatus
control group
Other group
Description:
inflation of a blood pressure cuff on the bilateral thighs to 40 mm Hg for four 5-minute intervals
Treatment:
Procedure: Remote Ischemic Preconditioning Training Apparatus

Trial contacts and locations

1

Loading...

Central trial contact

wu shiwen, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems